Nanoveu Limited
NNVUF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $9 | $8 | $5 | $3 |
| - Cash | $0 | $0 | $0 | $1 |
| + Debt | $0 | $0 | $0 | $1 |
| Enterprise Value | $8 | $8 | $5 | $3 |
| Revenue | $0 | $0 | $0 | $1 |
| % Growth | -90.2% | -35.7% | -80.8% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 153.2% | 24.6% | 17.1% | 43% |
| EBITDA | -$2 | -$1 | -$2 | -$1 |
| % Margin | -24,602.2% | -1,925.5% | -1,507.2% | -252.6% |
| Net Income | -$3 | -$2 | -$2 | -$2 |
| % Margin | -40,880.4% | -3,090.6% | -1,675.8% | -297.1% |
| EPS Diluted | -0.004 | -0.006 | -0.008 | -0.01 |
| % Growth | 36.2% | 26.6% | 18.6% | – |
| Operating Cash Flow | -$2 | -$1 | -$1 | -$1 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$2 | -$1 | -$1 | -$1 |